Harm reduction is now the mainstream global drug policy

Addiction

Volumn 104, Issue 3, 2009, Pages 343-345

  Wodak, Alex ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Abstinence; Drug law enforcement; Effectiveness; Harm reduction; HIV AIDS; Prohibition

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; PSYCHOTROPIC AGENT;

ABSTINENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CAUSE OF DEATH; CLINICAL EVALUATION; CRIME; DISEASE SEVERITY; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG LEGISLATION; DRUG USE; EVIDENCE BASED PRACTICE; GLOBAL DRUG POLICY; GREENHOUSE EFFECT; HARM REDUCTION; HEALTH CARE COST; HEALTH CARE NEED; HEALTH PROGRAM; HEALTH SURVEY; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INJECTION; MALARIA; NEEDLE; NOTE; PANDEMIC; PATIENT SAFETY; PREVALENCE; SEIZURE; SMOKING; SOCIOECONOMICS; TUBERCULOSIS; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

DRUG AND NARCOTIC CONTROL; HARM REDUCTION; HEALTH POLICY; HUMANS; PUBLIC HEALTH; SUBSTANCE-RELATED DISORDERS;

EID: 59849115832     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02440.x     Document Type: Note

References (19)

1. Office of National Drug Control Policy. National Drug Control Strategy. Washington, DC : US Government Printing Office 1989.
2. Wood E., Tyndall M. W., Spittal P. M., Li K., Anis A. H., Hogg R. S. et al. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ 2003 168 : 165 9.
3. World Health Organization Expert Committee on Drug Dependence. Twentieth Report. Geneva : World Health Organization 1974. Available at: http://whqlibdoc.who.int/trs/WHO-TRS-551.pdf (accessed 9 September 2008).
4. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization. AIDS Epidemic Update. Geneva : UNAIDS 2007. Available at: http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf (accessed 9 September 2008).
5. Wodak A., Cooney A. Do Needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006 41 : 777 816.
6. World Health Organization, United Nations Office on Drugs and Crime & UNAIDS. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper of the WHO, UN Office on Drugs and Crime and UNAIDS. Geneva : WHO 2004. Available at: http://www.who.int/substance- abuse/publications/en/PositionPaper-English.pdf. (accessed 9 September 2008).
7. Weatherburn D. Dilemmas in harm minimization. Addiction 2009 104 : 335 9.
8. Committee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries. Preventing HIV Infection among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence. Washington, DC : Institute of Medicine of the National Academies (The National Academies Press) 2006. Available at: http://books.nap.edu/openbook.php?record-id=11731&page=R1 (accessed 9 September 2008).
9. McSweeney T., Turnbull P. J., Hough M. Tackling Drug Markets and Distribution Networks in the UK; A Review of the Recent Literature. London : Institute for Criminal Policy Research 2008.
10. Friedman S. R., Cooper H. L. F., Tempalski B., Keem M., Friedman R., Flom P. L. et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006 20 : 93 9.
11. Executive Office of the President, Office of National Drug Control Policy. Technical Report for the Price and Purity of Illicit Drugs, 1981 Through the Second Quarter of 2003. Washington, DC : Rand Corporation 2004. Available at: http://www.whitehousedrugpolicy.gov/publications/price-purity-tech-rpt/ price-purity-tech-rpt.pdf (accessed 9 September 2008).
12. Storti C. C., De Grauwe P. Globalization and the Price Decline of Illicit Drug: CESifo Working Paper No. 1990. Munich : Ifo Institute for Economic Research 2007. Available at: http://www.cesifogroup.de/pls/guestci/download/ CESifo%20Working%20Papers%202007/CESifo%20Working%20Papers%20May%202007/ cesifo1-wp1990.pdf (accessed 9 September 2008).
13. United Nations International Drug Control Programme (UNDCP). General Assembly Twentieth Special Session: A Drug-Free World, We Can Do It. Geneva : UNDCP 1998. Available at: http://www.un.org/ga/20special/presskit/pubinfo/ gassbro.htm (accessed 9 September 2008).
14. United Nations Office on Drugs and Crime (UNODC) 2008. World Drug Report. Vienna : UNODC 2008. Available at: http://www.unodc.org/documents/wdr/WDR-2008/ WDR-2008-eng-web.pdf (accessed 9 September 2008).
15. Rydell C. P., Everingham S. S. Controlling cocaine. Supply versus Demand Programs. Prepared for the Office of National Drug Control Policy United States Army. Santa Monica : RAND Corporation 1994. http://www.rand.org/pubs/monograph- reports/MR331/ (accessed 9 September 2008).
16. Zábranský T., Mravcík V., Gajdoší ková H., Miovský, M. PAD: Impact Analysis Project of New Drugs Legislation (Summary Final Report). Prague : Office of the Czech Government, Secretariat of the National Drug Commission 2001. Available at: http://www.ak-ps.cz/client/files/PAD-en.pdf (accessed 9 September 2008).
17. Reinarman C., Cohen P. D. A., Kaal H. L. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health 2004 94 : 836 42.
18. Cabinet Office Strategy Unit. Strategy Unit Drugs Project. Phase 1 Report: Understanding the Issues. London : Cabinet Office 2003. Available at: http://www.cabinetoffice.gov.uk/Sites/www.cabinetoffice.gov.uk/strategy/ work-areas/%7E/media/assets/www.cabinetoffice.gov.uk/strategy/ drugs-report%20pdf.ashx (accessed 9 September 2008).
19. Select Committee on Home Affairs. The Government's Drugs Policy: Is It Working? London : House of Commons 2002. Available at: http://www.publications. parliament.uk/pa/cm200102/cmselect/cmhaff/318/31803.htm (accessed 9 September 2008).